SI3504210T1 - 7-substituirane sulfonimidoilpurinonske spojine za zdravljenje virusne okužbe in zaščito pred njo - Google Patents
7-substituirane sulfonimidoilpurinonske spojine za zdravljenje virusne okužbe in zaščito pred njoInfo
- Publication number
- SI3504210T1 SI3504210T1 SI201730728T SI201730728T SI3504210T1 SI 3504210 T1 SI3504210 T1 SI 3504210T1 SI 201730728 T SI201730728 T SI 201730728T SI 201730728 T SI201730728 T SI 201730728T SI 3504210 T1 SI3504210 T1 SI 3504210T1
- Authority
- SI
- Slovenia
- Prior art keywords
- prophylaxis
- treatment
- virus infection
- substituted
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/24—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2016097140 | 2016-08-29 | ||
| CN2017092653 | 2017-07-12 | ||
| PCT/EP2017/071514 WO2018041763A1 (en) | 2016-08-29 | 2017-08-28 | 7-substituted sulfonimidoylpurinone compounds for the treatment and prophylaxis of virus infection |
| EP17758527.0A EP3504210B1 (en) | 2016-08-29 | 2017-08-28 | 7-substituted sulfonimidoylpurinone compounds for the treatment and prophylaxis of virus infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3504210T1 true SI3504210T1 (sl) | 2021-08-31 |
Family
ID=59738346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201730728T SI3504210T1 (sl) | 2016-08-29 | 2017-08-28 | 7-substituirane sulfonimidoilpurinonske spojine za zdravljenje virusne okužbe in zaščito pred njo |
Country Status (31)
| Country | Link |
|---|---|
| US (3) | US10233184B2 (sl) |
| EP (2) | EP3504210B1 (sl) |
| JP (2) | JP7013467B2 (sl) |
| KR (2) | KR102459155B1 (sl) |
| CN (1) | CN109641904B (sl) |
| AU (3) | AU2017320742B2 (sl) |
| BR (1) | BR112019003519A2 (sl) |
| CA (1) | CA3034148A1 (sl) |
| CL (1) | CL2019000512A1 (sl) |
| CO (1) | CO2019000932A2 (sl) |
| CR (1) | CR20190087A (sl) |
| DK (1) | DK3504210T3 (sl) |
| ES (1) | ES2867849T3 (sl) |
| HR (1) | HRP20210621T1 (sl) |
| HU (1) | HUE053944T2 (sl) |
| IL (3) | IL293475A (sl) |
| MA (1) | MA46038B1 (sl) |
| MX (2) | MX2019002129A (sl) |
| MY (1) | MY197408A (sl) |
| NZ (1) | NZ750604A (sl) |
| PE (1) | PE20190476A1 (sl) |
| PH (1) | PH12019500432A1 (sl) |
| PL (1) | PL3504210T3 (sl) |
| PT (1) | PT3504210T (sl) |
| RS (1) | RS61752B1 (sl) |
| RU (1) | RU2751349C2 (sl) |
| SG (2) | SG11201901633WA (sl) |
| SI (1) | SI3504210T1 (sl) |
| TW (1) | TWI671300B (sl) |
| UA (1) | UA124270C2 (sl) |
| WO (1) | WO2018041763A1 (sl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2745269C2 (ru) * | 2015-05-08 | 2021-03-22 | Ф. Хоффманн-Ля Рош Аг | Новые соединения и производные сульфонимидоилпуринона для лечения и профилактики вирусной инфекции |
| MA46038B1 (fr) * | 2016-08-29 | 2021-05-31 | Hoffmann La Roche | Composés de sulfonimidoylpurinone substitués dans la position 7 pour le traitement et la prophylaxie d'infection virale |
| ES2894605T3 (es) * | 2016-09-13 | 2022-02-15 | Hoffmann La Roche | Tratamiento combinado con un agonista de TLR7 y un inhibidor del ensamblaje de la cápside del VHB |
| WO2019155042A1 (en) | 2018-02-12 | 2019-08-15 | F. Hoffmann-La Roche Ag | Novel sulfone compounds and derivatives for the treatment and prophylaxis of virus infection |
| EP3758707A1 (en) * | 2018-02-28 | 2021-01-06 | F. Hoffmann-La Roche AG | 7-substituted sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of liver cancer |
| KR20210081332A (ko) | 2018-09-12 | 2021-07-01 | 실버백 테라퓨틱스, 인크. | 면역 자극성 접합체를 사용한 질환의 치료를 위한 조성물 |
| JP7287708B2 (ja) | 2019-02-08 | 2023-06-06 | プロジェニア インコーポレイテッド | Ｔｏｌｌ－ｌｉｋｅ受容体７または８アゴニストとコレステロールの結合体およびその用途 |
| WO2021067644A1 (en) | 2019-10-01 | 2021-04-08 | Silverback Therapeutics, Inc. | Combination therapy with immune stimulatory conjugates |
| JP2023514727A (ja) | 2020-02-21 | 2023-04-07 | シルバーバック セラピューティックス インコーポレイテッド | ネクチン－４抗体コンジュゲートおよびその使用 |
| US20230100429A1 (en) | 2020-03-02 | 2023-03-30 | Progeneer Inc. | Live-pathogen-mimetic nanoparticles based on pathogen cell wall skeleton, and production method thereof |
| TW202216211A (zh) | 2020-07-01 | 2022-05-01 | 美商希沃爾拜克治療公司 | 抗asgr1抗體共軛物及其用途 |
| EP4194008A1 (en) | 2020-08-04 | 2023-06-14 | Progeneer Inc. | Kinetically acting adjuvant ensemble |
| US20230277525A1 (en) | 2020-08-04 | 2023-09-07 | Progeneer Inc | Conjugate of functional drug and toll-like receptor 7 or 8 agonist of which active site is temporarily inactivated and use thereof |
| EP4194006A1 (en) | 2020-08-04 | 2023-06-14 | Progeneer Inc. | Mrna vaccine comprising adjuvant capable of kinetic control |
| US20240124486A1 (en) * | 2020-09-27 | 2024-04-18 | Shanghai Visonpharma Co., Ltd. | Macrocyclic tlr7 agonist, preparation method therefor, pharmaceutical composition and use thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3485225D1 (de) * | 1983-08-18 | 1991-12-05 | Beecham Group Plc | Antivirale guanin-derivate. |
| WO1998001448A1 (fr) | 1996-07-03 | 1998-01-15 | Japan Energy Corporation | Nouveaux derives de purine |
| AUPO912997A0 (en) * | 1997-09-11 | 1997-10-02 | Commonwealth Scientific And Industrial Research Organisation | Antiviral agents |
| US6329381B1 (en) | 1997-11-28 | 2001-12-11 | Sumitomo Pharmaceuticals Company, Limited | Heterocyclic compounds |
| JPH11180981A (ja) * | 1997-12-19 | 1999-07-06 | Sumitomo Pharmaceut Co Ltd | 複素環誘導体 |
| TW572758B (en) | 1997-12-22 | 2004-01-21 | Sumitomo Pharma | Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives |
| JP4189048B2 (ja) * | 1997-12-26 | 2008-12-03 | 大日本住友製薬株式会社 | 複素環化合物 |
| JP5420135B2 (ja) * | 2002-03-15 | 2014-02-19 | ウエイン・ステイト・ユニバーシテイ | 抗ウイルス薬としての新規２−アミノ−９−［（２−ヒドロキシメチル）シクロプロピリデンメチル］プリン |
| AU2003271064B2 (en) * | 2002-09-27 | 2010-06-17 | Dainippon Sumitomo Pharma Co., Ltd. | Novel adenine compound and use thereof |
| JP2008540396A (ja) | 2005-05-04 | 2008-11-20 | ファイザー・リミテッド | 癌およびｃ型肝炎などのウイルス感染を治療するためのトール様受容体調節薬としての２−アミド−６−アミノ−８−オキソプリン誘導体 |
| DE102006053049A1 (de) | 2006-11-10 | 2008-05-15 | Daimler Ag | Staufach mit einer Abdeckeinrichtung |
| CN101784548B (zh) * | 2007-06-29 | 2013-07-17 | 吉里德科学公司 | 嘌呤衍生物及其作为toll样受体7的调节剂的用途 |
| CN101239980B (zh) | 2008-02-18 | 2011-06-22 | 靳广毅 | 免疫受体调节剂偶联体前体和偶联体及其应用 |
| WO2010077613A1 (en) * | 2008-12-09 | 2010-07-08 | Gilead Sciences, Inc. | Modulators of toll-like receptors |
| ES2644286T3 (es) * | 2009-10-22 | 2017-11-28 | Gilead Sciences, Inc. | Derivados de purina o deazapurina útiles para el tratamiento de (entre otros) infecciones víricas |
| US20110150836A1 (en) | 2009-12-22 | 2011-06-23 | Gilead Sciences, Inc. | Methods of treating hbv and hcv infection |
| US8501724B1 (en) * | 2012-01-31 | 2013-08-06 | Pharmacyclics, Inc. | Purinone compounds as kinase inhibitors |
| PL3190113T3 (pl) | 2014-08-15 | 2021-10-25 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Związki pirolopirymidynowe stosowane jako agonista TLR7 |
| RU2745269C2 (ru) * | 2015-05-08 | 2021-03-22 | Ф. Хоффманн-Ля Рош Аг | Новые соединения и производные сульфонимидоилпуринона для лечения и профилактики вирусной инфекции |
| MA46038B1 (fr) * | 2016-08-29 | 2021-05-31 | Hoffmann La Roche | Composés de sulfonimidoylpurinone substitués dans la position 7 pour le traitement et la prophylaxie d'infection virale |
-
2017
- 2017-08-28 MA MA46038A patent/MA46038B1/fr unknown
- 2017-08-28 SG SG11201901633WA patent/SG11201901633WA/en unknown
- 2017-08-28 TW TW106129087A patent/TWI671300B/zh active
- 2017-08-28 RS RS20210489A patent/RS61752B1/sr unknown
- 2017-08-28 CN CN201780052692.6A patent/CN109641904B/zh active Active
- 2017-08-28 RU RU2019107957A patent/RU2751349C2/ru active
- 2017-08-28 DK DK17758527.0T patent/DK3504210T3/da active
- 2017-08-28 IL IL293475A patent/IL293475A/en unknown
- 2017-08-28 MY MYPI2019001082A patent/MY197408A/en unknown
- 2017-08-28 IL IL284255A patent/IL284255B/en unknown
- 2017-08-28 PL PL17758527T patent/PL3504210T3/pl unknown
- 2017-08-28 KR KR1020197008982A patent/KR102459155B1/ko active Application Filing
- 2017-08-28 JP JP2019532184A patent/JP7013467B2/ja active Active
- 2017-08-28 CA CA3034148A patent/CA3034148A1/en active Pending
- 2017-08-28 SG SG10202010520SA patent/SG10202010520SA/en unknown
- 2017-08-28 NZ NZ750604A patent/NZ750604A/en unknown
- 2017-08-28 EP EP17758527.0A patent/EP3504210B1/en active Active
- 2017-08-28 BR BR112019003519-2A patent/BR112019003519A2/pt unknown
- 2017-08-28 HU HUE17758527A patent/HUE053944T2/hu unknown
- 2017-08-28 PE PE2019000346A patent/PE20190476A1/es unknown
- 2017-08-28 WO PCT/EP2017/071514 patent/WO2018041763A1/en active Application Filing
- 2017-08-28 MX MX2019002129A patent/MX2019002129A/es unknown
- 2017-08-28 AU AU2017320742A patent/AU2017320742B2/en active Active
- 2017-08-28 CR CR20190087A patent/CR20190087A/es unknown
- 2017-08-28 EP EP20207475.3A patent/EP3865482A1/en not_active Withdrawn
- 2017-08-28 SI SI201730728T patent/SI3504210T1/sl unknown
- 2017-08-28 PT PT177585270T patent/PT3504210T/pt unknown
- 2017-08-28 KR KR1020227036198A patent/KR20220147702A/ko not_active Application Discontinuation
- 2017-08-28 UA UAA201903059A patent/UA124270C2/uk unknown
- 2017-08-28 ES ES17758527T patent/ES2867849T3/es active Active
- 2017-08-29 US US15/689,136 patent/US10233184B2/en active Active
-
2019
- 2019-01-29 US US16/260,744 patent/US10752630B2/en active Active
- 2019-01-30 CO CONC2019/0000932A patent/CO2019000932A2/es unknown
- 2019-02-07 IL IL264710A patent/IL264710B/en unknown
- 2019-02-21 MX MX2021006902A patent/MX2021006902A/es unknown
- 2019-02-26 CL CL2019000512A patent/CL2019000512A1/es unknown
- 2019-02-27 PH PH12019500432A patent/PH12019500432A1/en unknown
-
2020
- 2020-08-24 US US17/001,572 patent/US20200385387A1/en not_active Abandoned
-
2021
- 2021-04-19 HR HRP20210621TT patent/HRP20210621T1/hr unknown
- 2021-06-24 AU AU2021204303A patent/AU2021204303B2/en active Active
-
2022
- 2022-01-17 JP JP2022004832A patent/JP7214900B2/ja active Active
- 2022-06-30 AU AU2022204697A patent/AU2022204697A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL284255A (en) | 7-substituted sulfonimidylpurinone compounds for the treatment and prevention of viral infection | |
| HK1251554A1 (zh) | 用於治療和預防病毒感染的新的取代的氨基噻唑並嘧啶二酮 | |
| HK1248711A1 (zh) | 用於治療和預防病毒感染的新的取代的氨基噻唑並嘧啶二酮 | |
| HRP20190352T1 (hr) | Novi 6-kondenzirani heteroarildihidropirimidini za liječenje i profilaksu infekcije virusom hepatitisa b | |
| HUS2200053I1 (hu) | HIV vírusfertõzés megelõzõ vagy terápiás kezelésére alkalmas terápiás vegyületek | |
| HK1251221A1 (zh) | 用於治療和預防乙型肝炎病毒感染的新的三環4-吡啶酮-3-甲酸衍生物 | |
| HK1251220A1 (zh) | 用於治療和預防乙型肝炎病毒感染的新的四環4-氧代-吡啶-3-甲酸衍生物 | |
| HK1223931A1 (zh) | 用於治療和預防乙型肝炎病毒感染的新型二氫喹嗪酮類化合物 | |
| IL263972A (en) | Dihydropyranopyrimidines for the treatment of viral infections | |
| IL280769A (en) | New sulfonimidylpurinone compounds and their history for the treatment and prevention of virus infection | |
| HK1252343A1 (zh) | 用於治療病毒感染的組合物和方法 | |
| ZA201900770B (en) | 7-substituted sulfonimidoylpurinone compounds for the treatment and prophylaxis of virus infection | |
| LT3504210T (lt) | Nauji 7 padėtyje pakeisti sulfonimidoilpurinono junginiai, skirti viruso sukeliamos infekcijos gydymui ir profilaktikai | |
| ZA201604784B (en) | Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection |